These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16426542)

  • 1. [Prognostic influence of immunological subtypes of T-cell acute lymphoblastic leukemia. Study of 81 patients].
    Xicoy B; Ribera JM; Oriol A; Sanz MA; Abella E; Tormo M; del Potro E; Bueno J; Grande C; Fernández-Calvo J; Orts M; Novo A; Rivas C; Hernández-Rivas JM; Feliu E; Ortega JJ
    Med Clin (Barc); 2006 Jan; 126(2):41-6. PubMed ID: 16426542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological subtypes of childhood T-cell acute lymphoblastic leukemia and their prognostic significance].
    Proleskovskaia IV; Buglova SE; Aleĭnikova OV
    Vopr Onkol; 2002; 48(3):322-6. PubMed ID: 12455355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
    Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
    Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates.
    Yanada M; Jinnai I; Takeuchi J; Ueda T; Miyawaki S; Tsuzuki M; Hatta Y; Usui N; Wada H; Morii T; Matsuda M; Kiyoi H; Okada M; Honda S; Miyazaki Y; Ohno R; Naoe T
    Leuk Res; 2007 Jul; 31(7):907-14. PubMed ID: 17005250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
    Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia.
    Shimizu H; Handa H; Hatsumi N; Takada S; Saitoh T; Sakura T; Miyawaki S; Nojima Y
    Eur J Haematol; 2013 Apr; 90(4):301-7. PubMed ID: 23425206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
    Steinherz PG; Gaynon PS; Breneman JC; Cherlow JM; Grossman NJ; Kersey JH; Johnstone HS; Sather HN; Trigg ME; Uckun FM; Bleyer WA
    Cancer; 1998 Feb; 82(3):600-12. PubMed ID: 9452280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
    Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
    Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
    Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
    Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are "early" and "late" T-acute lymphoblastic leukemias different diseases? A single center study of 34 patients.
    Cascavilla N; Musto P; D'Arena G; Ladogana S; Melillo L; Carella AM; Perla G; Matera R; Carotenuto M
    Leuk Lymphoma; 1996 May; 21(5-6):437-42. PubMed ID: 9172808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL).
    Jabbour E; Koscielny S; Sebban C; Peslin N; Patte C; Gargi T; Biron P; Fermé C; Bourhis JH; Vantelon JM; Arnaud P; Ribrag V
    Leukemia; 2006 May; 20(5):814-9. PubMed ID: 16511514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence and prognostic significance of myeloid markers in adults with high-risk acute lymphoblastic leukemia].
    Plensa E; Ribera JM; Oriol A; Bethencourt C; Parody R; Hernández Ribas JM; Moreno MJ; del Potro E; Tormo M; Rivas C; Besalduch J; Sanz MA; Arias J; Fernández Calvo J; Moraleda JM; Bueno J; Feliu E; Ortega JJ;
    Med Clin (Barc); 2005 Sep; 125(7):241-6. PubMed ID: 16137483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of clinical picture (event free survival and overall survival) in childhood acute leukemia patients with immunophenotype and chromosomal abnormalities.
    Babusíková O; Sejnová D; Kirschnerová G; Kirsnerová Z; Cáp J
    Neoplasma; 2000; 47(6):382-9. PubMed ID: 11263863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study.
    Uckun FM; Reaman G; Steinherez PG; Arthur DC; Sather H; Trigg M; Tubergen D; Gaynon P
    Leuk Lymphoma; 1996 Dec; 24(1-2):57-70. PubMed ID: 9049962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D; Gökbuget N
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
    Goldberg JM; Silverman LB; Levy DE; Dalton VK; Gelber RD; Lehmann L; Cohen HJ; Sallan SE; Asselin BL
    J Clin Oncol; 2003 Oct; 21(19):3616-22. PubMed ID: 14512392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.
    Hodson A; Crichton S; Montoto S; Mir N; Matutes E; Cwynarski K; Kumaran T; Ardeshna KM; Pagliuca A; Taylor GP; Fields PA
    J Clin Oncol; 2011 Dec; 29(35):4696-701. PubMed ID: 22042945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
    Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
    Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of adult acute lymphoblastic leukemia.
    Laport GF; Larson RA
    Semin Oncol; 1997 Feb; 24(1):70-82. PubMed ID: 9045306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.